OrthoAccel Technologies

About:

OrthoAccel Technologies develops and manufactures an acceleration device for orthodontics.

Website: http://www.acceledent.com/home

Twitter/X: acceledent

Top Investors: S3 Ventures, Piper Sandler, HealthpointCapital, Comerica Incorporated, Houston Angel Network

Description:

OrthoAccel Technologies (OATI) designs, develops, markets, and sells the most revolutionary device in orthodontics – the Celerect 1000 – that cuts treatment time for braces in half and works in combination with all existing orthodontic bracket technologies. This proprietary technology (three issued patents) is licensed from the University of Illinois at Chicago and the company has engaged the leading researchers in this field including the inventor, Dr. Jeremy Mao, at Columbia University, Baylor College of Dentistry, and the University of Texas Health Sciences Center, Dental Branch. Together with these world-class partners, management will commercialize this innovation by 2009.

Total Funding Amount:

$82.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2007-02-01

Contact Email:

info(AT)orthoaccel.com

Founders:

Mike Lowe

Number of Employees:

51-100

Last Funding Date:

2019-05-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai